Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lisata Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lisata Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Klosk Steven M | Director | 95,815 | Jan 13, 2026 | 1 |
| Henson Heidi | Director | 85,725 | Jan 13, 2026 | 1 |
| Azab Mohammad | Director | 104,925 | Jan 13, 2026 | 1 |
| Mazzo David J | President & CEO | 311,890 | Jan 13, 2026 | 1 |
| Brown Gregory B | Director | 95,659 | Jan 13, 2026 | 1 |
| Flowers Cynthia Louise | Director | 95,446 | Jan 13, 2026 | 1 |
| Buck Kristen K | EVP, R&D and CMO | 93,462 | Jan 13, 2026 | 1 |
| Nisco James | SVP, Fin/Treas, Chief Actg Off | 32,311 | Jan 13, 2026 | 1 |
| Imam Tariq | SVP, Bus Dev, General Counsel | 36,078 | Jan 13, 2026 | 1 |
| Ruoslahti Erkki | Director | 20,000 | Jan 11, 2023 | 0 |
| Slack David W. | President & CBO | 20,642 | Jan 11, 2023 | 0 |
| Girolamo Todd C | CLO, SVP of Corp Dev | 160,827 | Jan 18, 2022 | 0 |
| Myers Steven S | Director | 212,269 | Jan 12, 2022 | 0 |
| Traber Peter G | Director | 149,190 | Jan 12, 2022 | 0 |
| Davidson Michael H. | Director | 209,753 | Jan 12, 2022 | 0 |
| Whitaker Anne Clem | Director | 182,635 | Jan 12, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Myers Steven SDirector | PPurchase | +33.8K | $0.89 | +$30.1K | +29.9%146.8K after |